• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普通内科促进肥胖症护理公平性的机遇。

Opportunities for General Internal Medicine to Promote Equity in Obesity Care.

作者信息

Kane Ryan M, Nicklas Jacinda M, Schwartz Jessica L, Bramante Carolyn T, Yancy William S, Gudzune Kimberly A, Jay Melanie R

机构信息

Division of General Internal Medicine, Department of Medicine, Duke University, Durham, NC, USA.

Clinical and Translational Science Institute, Duke University, Durham, NC, USA.

出版信息

J Gen Intern Med. 2024 Oct 16. doi: 10.1007/s11606-024-09084-z.

DOI:10.1007/s11606-024-09084-z
PMID:39414737
Abstract

The number and complexity of obesity treatments has increased rapidly in recent years. This is driven by the approval of new anti-obesity medications (AOMs) that produce larger degrees of weight loss than previously approved AOMs. Unfortunately, access to these highly effective therapies and to integrated team-based obesity care is limited by intra-/interpersonal patient, institutional/practitioner, community, and policy factors. We contextualized these complexities and the impact of patients' social drivers of health (SDOH) by adapting the social ecological model for obesity. Without multi-level intervention, these barriers to care will deepen the existing inequities in obesity prevalence and treatment outcomes among historically underserved communities. As General Internal Medicine (GIM) physicians, we can help our patients navigate the complexities of evidence-based obesity treatments. As care team leaders, GIM physicians are well-positioned to (1) improve education for trainees and practitioners, (2) address healthcare-associated weight stigma, (3) advocate for equity in treatment accessibility, and (4) coordinate interdisciplinary teams around non-traditional models of care focused on upstream (e.g., policy changes, insurance coverage, health system culture change, medical education requirements) and downstream (e.g., evidence-based weight management didactics for trainees, using non-stigmatizing language with patients, developing interdisciplinary weight management clinics) strategies to promote optimal obesity care for all patients.

摘要

近年来,肥胖治疗的数量和复杂性迅速增加。这是由新的抗肥胖药物(AOMs)的获批推动的,这些药物比先前获批的AOMs能带来更大程度的体重减轻。不幸的是,患者个体/人际、机构/从业者、社区和政策因素限制了获得这些高效治疗方法以及基于团队的综合肥胖护理的机会。我们通过调整肥胖的社会生态模型,将这些复杂性以及患者健康的社会驱动因素(SDOH)的影响置于具体情境中。如果没有多层次干预,这些护理障碍将加深历史上服务不足社区在肥胖患病率和治疗结果方面现有的不平等。作为普通内科(GIM)医生,我们可以帮助患者应对循证肥胖治疗的复杂性。作为护理团队的领导者,GIM医生有能力(1)改善对实习生和从业者的教育,(2)解决与医疗保健相关的体重歧视问题,(3)倡导治疗可及性方面的公平,以及(4)围绕专注于上游(如政策变化、保险覆盖、卫生系统文化变革、医学教育要求)和下游(如为实习生提供循证体重管理教学、与患者使用无歧视性语言、建立跨学科体重管理诊所)策略的非传统护理模式协调跨学科团队,以促进为所有患者提供最佳的肥胖护理。

相似文献

1
Opportunities for General Internal Medicine to Promote Equity in Obesity Care.普通内科促进肥胖症护理公平性的机遇。
J Gen Intern Med. 2024 Oct 16. doi: 10.1007/s11606-024-09084-z.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Sexual Harassment and Prevention Training性骚扰与预防培训
4
Reducing health inequalities through general practice: a realist review and action framework.通过全科医疗减少健康不平等:一个现实主义综述和行动框架。
Health Soc Care Deliv Res. 2024 Mar;12(7):1-104. doi: 10.3310/YTWW7032.
5
Addressing Inequalities in Long Covid Healthcare: A Mixed-Methods Study on Building Inclusive Services.解决长期新冠医疗保健中的不平等问题:一项关于建立包容性服务的混合方法研究。
Health Expect. 2025 Aug;28(4):e70336. doi: 10.1111/hex.70336.
6
Overcoming Stigma and Bias in Obesity Management克服肥胖管理中的耻辱感和偏见
7
A New Measure of Quantified Social Health Is Associated With Levels of Discomfort, Capability, and Mental and General Health Among Patients Seeking Musculoskeletal Specialty Care.一种新的量化社会健康指标与寻求肌肉骨骼专科护理的患者的不适程度、能力以及心理和总体健康水平相关。
Clin Orthop Relat Res. 2025 Apr 1;483(4):647-663. doi: 10.1097/CORR.0000000000003394. Epub 2025 Feb 5.
8
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
9
Are Detailed, Patient-level Social Determinant of Health Factors Associated With Physical Function and Mental Health at Presentation Among New Patients With Orthopaedic Conditions?详细的患者层面的健康社会决定因素是否与新骨科患者就诊时的身体功能和心理健康相关?
Clin Orthop Relat Res. 2023 May 1;481(5):912-921. doi: 10.1097/CORR.0000000000002446. Epub 2022 Oct 6.
10
Implementation of link workers in primary care: Synopsis of findings from a realist evaluation.基层医疗中联络人员的实施:现实主义评价的结果概要
Health Soc Care Deliv Res. 2025 Jul;13(27):1-30. doi: 10.3310/KHGT9993.

引用本文的文献

1
Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society.支持胰高血糖素样肽-1治疗肥胖症的营养优先事项:美国生活方式医学学院、美国营养学会、肥胖医学协会和肥胖协会的联合咨询意见
Obes Pillars. 2025 Jun 3;15:100181. doi: 10.1016/j.obpill.2025.100181. eCollection 2025 Sep.
2
Nutritional Priorities to Support GLP-1 Therapy for Obesity: A Joint Advisory From the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society.支持胰高血糖素样肽-1治疗肥胖症的营养优先事项:美国生活方式医学学院、美国营养学会、肥胖医学协会和肥胖协会联合咨询意见
Am J Lifestyle Med. 2025 May 30:15598276251344827. doi: 10.1177/15598276251344827.
3

本文引用的文献

1
Identifying and Addressing Bias in Artificial Intelligence.识别与解决人工智能中的偏差
JAMA Netw Open. 2024 Aug 1;7(8):e2425955. doi: 10.1001/jamanetworkopen.2024.25955.
2
GLP-1 Agonists for Obesity-Reply.用于肥胖症的胰高血糖素样肽-1激动剂——回应
JAMA. 2024 Aug 27;332(8):675-676. doi: 10.1001/jama.2024.12077.
3
Eligibility for and Preventive Potential of Semaglutide in Overweight and Obese Patients With Myocardial Infarction.司美格鲁肽在超重和肥胖心肌梗死患者中的适用性及预防潜力
Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society.支持GLP-1治疗肥胖症的营养优先事项:美国生活方式医学学院、美国营养学会、肥胖医学协会和肥胖协会联合发布的咨询意见
Obesity (Silver Spring). 2025 May 30. doi: 10.1002/oby.24336.
4
The Impact of Novel Medications for Obesity on Weight Stigma and Societal Attitudes: A Narrative Review.新型肥胖药物对体重歧视和社会态度的影响:一项叙述性综述。
Curr Obes Rep. 2025 Feb 5;14(1):18. doi: 10.1007/s13679-025-00611-5.
5
Perceptions of Obesity Among Healthcare Professionals and Policy Makers in 2023: Results of the Global OPEN Survey.2023年医疗保健专业人员和政策制定者对肥胖的认知:全球OPEN调查结果
Obes Sci Pract. 2025 Jan 8;11(1):e70033. doi: 10.1002/osp4.70033. eCollection 2025 Feb.
J Am Coll Cardiol. 2024 Mar 5;83(9):956-958. doi: 10.1016/j.jacc.2023.12.029.
4
"Food Is Medicine" Strategies for Nutrition Security and Cardiometabolic Health Equity: JACC State-of-the-Art Review.《食物是良药》:保障营养安全和实现心血管代谢健康公平的策略:美国心脏病学会最新综述。
J Am Coll Cardiol. 2024 Feb 27;83(8):843-864. doi: 10.1016/j.jacc.2023.12.023.
5
A scoping review of obesity education interventions for current and prospective medical professionals in Canada.加拿大针对在职和未来医学专业人员的肥胖教育干预措施的范围综述。
Obes Pillars. 2023 Aug 19;8:100085. doi: 10.1016/j.obpill.2023.100085. eCollection 2023 Dec.
6
Obesity Management in Adults: A Review.成人肥胖管理:综述。
JAMA. 2023 Nov 28;330(20):2000-2015. doi: 10.1001/jama.2023.19897.
7
Artificial intelligence and obesity management: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023.人工智能与肥胖管理:肥胖医学协会(OMA)2023年临床实践声明(CPS)
Obes Pillars. 2023 Apr 20;6:100065. doi: 10.1016/j.obpill.2023.100065. eCollection 2023 Jun.
8
Colombia introduces Latin America's first junk food tax.哥伦比亚推出了拉丁美洲首个垃圾食品税。
BMJ. 2023 Nov 15;383:2698. doi: 10.1136/bmj.p2698.
9
Impact on Knowledge, Competence, and Performance of a Faculty-Led Web-Based Educational Activity for Type 2 Diabetes and Obesity: Questionnaire Study Among Health Care Professionals and Analysis of Anonymized Patient Records.教师主导的基于网络的2型糖尿病和肥胖症教育活动对知识、能力和表现的影响:医疗保健专业人员问卷调查及匿名患者记录分析
JMIR Form Res. 2023 Sep 13;7:e49115. doi: 10.2196/49115.
10
Obesity-induced and weight-loss-induced physiological factors affecting weight regain.肥胖诱导及减肥诱导的影响体重反弹的生理因素。
Nat Rev Endocrinol. 2023 Nov;19(11):655-670. doi: 10.1038/s41574-023-00887-4. Epub 2023 Sep 11.